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The unprecedented, explosive growth of the COVID-19 domain presents challenges to
researchers to keep up with research knowledge within the domain. This article profiles
this research to help make that knowledge more accessible via overviews and novel
categorizations. We provide websites offering means for researchers to probe more
deeply to address specific questions. We further probe and reassemble COVID-19
topical content to address research issues concerning topical evolution and emphases
on tactical vs. strategic approaches to mitigate this pandemic and reduce future viral
threats. Data suggest that heightened attention to strategic, immunological factors is
warranted. Connecting with and transferring in research knowledge from outside the
COVID-19 domain demand a viable COVID-19 knowledge model. This study provides
complementary topical categorizations to facilitate such modeling to inform future
Literature-Based Discovery endeavors.
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INTRODUCTION
Never before has there been an explosion of research literature like that taking place this year on
COVID-19 [COVID-19 stands for COrona VIrus Disease, 2019, due to the (novel) SARS-CoV-2
virus strain]. This rich literature attracts bibliometric community attention to develop data-driven
methods and discover insightful knowledge for specific research questions, e.g., investigating the
reaction of scientific communities to the COVID-19 crisis (Zhang L. et al., 2020), identifying the
patterns of international collaboration (Fry et al., 2020), and profiling COVID-19–related research
topics from a scientometric perspective (Colavizza et al., 2020).
We treat a core COVID-19/coronavirus research collection from 1949 through July 1, 2020.
With US National Science Foundation (NSF) support (see Funding), we will update biweekly
into 2021 to monitor shifting research emphases. Thus, we gain a prior position to mine this
rich information resource to (1) profile the explosively growing research and communicate
concerning it so as to make findings more accessible to researchers and research managers
and (2) pursue Literature-Based Discovery (LBD) techniques to help link research findings to
COVID-19 concerns.
We address challenges that entail exploring the dynamics of this remarkable research domain,
with specific questions:
➢ Does COVID-19–related research constitute one or more research communities?
➢ How are the players connected? What collaboration patterns over disciplines and countries
determine research knowledge transfer (or lack thereof)?
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➢ How do research topics congregate? How are research
threads connecting or separating in the rapid evolution of
this domain?
Section Results Part 1: COVID-19 Research Profile categorizes
the research profiling in terms of basic “4W” questions for
this research landscape: Who? Where? When? What? We then
analyze the research to probe topical emphases and relationships.
We examine which topics show accelerating attention in the
core research literature over recent months. We then focus
on extracting empirical evidence on which of a set of factors
pertaining to pandemic resolution are being pursued in the core
COVID-19 literature.
As noted, we aspire to uncover useful research knowledge
by gaining perspective on the research patterns and helping
topical experts identify and associate research threads. We use
an approach of scientific evolutionary pathways (SEPs) (Zhang
et al., 2017) to identify research topics and communities and
track their predecessor-descendant relationships, for the core
literature, covering the time period from 1949 to July 1, 2020.
We observe eight major research threads comprising the
technical backbone of coronavirus research. COVID-19 connects
with influenza and the two pandemics—SARS, 2003, and
MERS, 2013. The rising concerns of the public on public
health and epidemiology (e.g., quarantine, early detection, and
susceptible populations) can be traced during the COVID-19
crisis. However, we also notice a low semantic similarity between
topics generated in 2020 and those of previous research, which
might indicate novel clinical characteristics of COVID-19 and
insufficient knowledge resident in research communities on
handling this crisis to date.
We lastly suggest future research challenges regarding this
speeding domain.
BACKGROUND
We blend bibliometric (c.f., De Bellis, 2009) and text mining
methods (c.f., Porter and Cunningham, 2005; Glänzel et al., 2019;
Ranaei et al., 2019) to profile research literature (Porter et al.,
2002; Zhou et al., 2014).
The bibliometric community has tracked the development
and trajectory of many Science, Technology & Innovation (ST&I)
domains, including emerging domains (c.f., Guan and Liu, 2014;
Glänzel et al., 2019). Our research group has contributed actively
to analyses of emerging technologies. In this article, we apply
our Tech Emergence Indicator (Carley et al., 2018; Porter et al.,
2018) to COVID-19. We have analyzed various emerging ST&I
domains, including nanotechnology subtopics, such as solid lipid
nanoparticles (Zhou et al., 2019), nano energy (Li et al., 2017),
and nano-enabled drug delivery (Ma et al., 2016); solar cells
via advanced text analysis (Wang et al., 2015); big data (Zhang
et al., 2016, 2019); 3D printing (Huang et al., 2017); and synthetic
biology (Shapira et al., 2017). None of those fields have shown
growth anything like that of COVID-19 research. COVID-19
is a different focus than an emerging technology—addressing
different aspects relating to a viral infection pandemic. Moreover,
its research literature is exploding.
Our interests include mapping the leading players and their
interconnections, as these evolve over time. Such networking
analyses can help understand the research community and detect
possible gaps (e.g., opportunities to connect players and topics
that could be synergistic) (Huang et al., 2019). It can be fruitful,
as well, to explore connections across fields and the involvement
of “border fields” (Porter et al., 2019). Transfer of research
knowledge to clinical practice poses many challenges (c.f., Ma
et al., 2019); COVID-19 confronts special such challenges as a
global pandemic.
As noted, our research aspires to identify COVID-19
opportunities for LBD efforts to follow. We want to elicit
coronavirus attributes and contributing factors, related
biomechanisms and biomarkers, and treatment modalities.
Pioneering LBD development traces to Swanson (1986)
discovery of a potential treatment for constriction of smaller
arteries in the extremities (Raynaud disease) hitherto not
considered in the literature on the disease. By finding common
elements, Swanson was able to bridge separated research
knowledge, opening up new opportunities. Gordon and Lindsay
(1996) extended Swanson’s explorations on Raynaud disease.
Swanson and Smalheiser (1997) developed the LBD analytical
processes. Smalheiser and colleagues (Smalheiser and Swanson,
1998; Smalheiser et al., 2009) made the analytical process much
more accessible via software – tools Arrowsmith.1
LBD seeks to infer novel, credible, and informative knowledge
by explicitly or implicitly associating two or more disparate
literature concepts (Bruza and Weeber, 2008; Ittipanuvat et al.,
2014). Its benefits have been pursued by bibliometric researchers
and applied for a variety of practical issues, especially in
biomedical domains, such as the exploration of potential
treatments or gene candidates for diseases (Kostoff et al., 2018;
Wu et al., 2020) and uncovering new therapeutic uses for existing
drugs (Ding et al., 2013). However, despite high potentials
in interdisciplinary research (Small, 2010), LBD still entails
a set of problem-driven and/or domain-specific approaches.
From a bibliometric perspective, the core methodologies of
LBD have been recognized as co-occurrence analysis, which
quantifies concepts and relationships with the intention of
knowledge inference, such as co-word and co-citation statistics
(Lindsay and Gordon, 1999). Those core methodologies are
further enhanced by incorporating network analytics, such as
heterogeneous network analytics (Sebastian et al., 2017) and link
prediction (Kastrin et al., 2016). Beyond that, novel techniques
including neural network embedding (Crichton et al., 2018;
Wu et al., 2020) and recommender systems (Lever et al., 2018)
also stand at the forefront of the LBD trend but have yet
not formed a mature research paradigm. Apart from those
existing methodologies, domain knowledge becomes necessary
for constructing references, taxonomies, and knowledge bases.
Inspired by these pioneer studies, our pilot study simulates
literature in a bibliometric stream and develops an approach
of streaming data analytics to identify and visualize topics
and their relationships over time as evolutionary pathways
(Zhang et al., 2017). These efforts provide an adaptable tool of
1See the website: http://arrowsmith.psych.uic.edu/arrowsmith_uic/index.html.
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intelligent bibliometrics for conducting LBD in a broad range of
technological areas and research domains, with limited expert
support (Zhang Y. et al., 2020). Those form the main techniques
exploited in the analysis of topical evolution in this article to
identify further LBD opportunities regarding COVID-19 and
beyond (to help mitigate future threats).
MATERIALS AND METHODS
The dramatic growth of COVID-19 research literature—refereed
journal articles, preprints, etc.—has been accompanied by
the emergence of multiple information resources. Websites
compiling related research information include the following:
➢ from the Centers for Disease Control: https://www.
coronavirus.gov
➢ from the National Institutes of Health: https://www.nih.gov/
coronavirus
➢ from the National Center for Biotechnology
Information: https://www.ncbi.nlm.nih.gov/sars-cov-2/
➢ the consortial CORD-19 (COVID-19 Open Research
Dataset), including query (same standard COVID-19 core
with related coronavirus research, provided by NLM, that we
use) results from the PubMed Central database (an expanded
version of PubMed); bioRxiv and medRxiv preprints; and
World Health Organization (WHO) articles—compiled by
a partnership including Allen Institute for AI (AI2—https://
scisight.apps.allenai.org), the Chan Zuckerberg Initiative,
Georgetown University’s Center for Security and Emerging
Technology, Microsoft Research (MSR), NLM, the White
House, and Unpaywall.2 See https://www.kaggle.com/allen-
institute-for-ai/CORD-19-research-challenge
➢ fromMIT Press, a site including social media content: https://
www.mitpressjournals.org/doi/abs/10.1162/qss_a_00066.
Bibliometric and “tech mining” analyses thus have multiple
candidate resources with various attributes. Selection entails
tradeoffs of coverage, currency, indexing, peer review or
not, abstract records or full text, etc. In our NSF project,
we intend to complement the use of a core PubMed
dataset with clinical trials.gov and WoS. Some variations
include the following: Haghani and Bliemer (2020) and
Homolak et al. (2020) used Scopus as well; Liu et al.
(2020) complemented PubMed with EMBASE; Niehs’ group
(https://www.collabovid.org) draw upon PubMed, Elsevier,
and three preprint resources—medRxiv, bioRxiv, and arXiv.
Lima et al. (2020) reviewed the domain drawing upon
PubMed, Scopus, Cochrane Library, and Biblioteca Virtual
de Saude (BVS).
Our core COVID-19 search is conducted in the PubMed
database [https://www.ncbi.nlm.nih.gov/pmc]. The National
Library of Medicine (NLM) therein provides compiled abstract
records that can be downloaded openly3. We apply the standard
2Colavizza et al. (2020) analyzed CORD-19 (46,996 records), comparing toWeb of
Science (WoS) and identifying interesting “macrotopics.”
3Since June, the interface limits downloads to the first 10,000 records, so we ran a
combination of partial searches. We did so using separate searches this time, for
NLM COVID-19, inclusive of historical research literature,
search query:
➢ “COVID-19” OR coronavirus OR “corona virus” OR “2019-
nCoV” OR “SARS-CoV” OR “MERS-CoV” OR “severe
acute respiratory syndrome” OR “Middle East respiratory
syndrome4.”
We use the legacy version of the PubMed database [by shifting
from “PMC” via pull-down to “PubMed”] on the website.5
NLM offers alternative COVID-19–oriented search queries; this
one focuses on COVID-19, but also provides relevant historical
research literature on coronaviruses, etc.
On September 6, 2020, afternoon, we ran some data
comparisons. The NLM search query that we applied links to an
NLM site with the standard search query preloaded. This query
version is the NLM “coronavirus broadly (historical and current
research)” version. It yields the following:
➢ 70,193 in PubMed (legacy) database
[for 1949–2021; of which 51,734 date 2020 or 2021 (a nominal
27 publications, indicating a certain lack of accuracy in
the dating)]
[contrast that to the 47,607 in our analyses based on PubMed
(legacy) search on July 1—up almost 50% in 2 months!]
➢ 97,457 in PMC (PubMed Central)
[this extends coverage to more preprints and such—more
current, but less controlled publication types]
➢ This NLM search site offers a choice of some 30 alternative
databases to search. Running the same search query in “All
Databases” finds hits in various research literature, gene,
protein, genome, and genetics databases.
[Our focus is on research literature, so the most suitable
choices are PMC (wider coverage) or PubMed (better
controlled and indexed content).]
➢ The CORD-19 Open Research Dataset (noted above) shows
more than 200,000 articles, including about half with full text
(not suitable for our present comparative analyses).
We also compared certain published work on COVID-19. For
example, Colavizza et al. (2020) focused on the CORD-19 dataset,
but facilitated altmetric data (e.g., Twitter and Blogs) to track
the dissemination of publications across various social media
sources. Fry et al. (2020) conducted their COVID-19 search
based on PMC-sourcedmaterials from the CORD-19, as well, but
select year sets (the interface gives a slider to choose years) and complementary
“AND/NOT” searches. For instance, one query added “AND clinical” to the core
query and downloaded resulting records; that was followed by another query
adding “NOT clinical” to get record sets within the 10,000 limit. We recombine
the downloaded sets in VantagePoint on the desktop, remove duplicates, perform
essential data cleaning and consolidation, and then post on our indicated website.
4In MEDLINE detail: “COVID-19”[All Fields] OR (“coronavirus”[MeSH Terms]
OR “coronavirus”[All Fields]) OR “corona virus”[All Fields] OR “2019-
nCoV”[All Fields] OR “SARS-CoV”[All Fields] OR “MERS-CoV”[All Fields] OR
“severe acute respiratory syndrome”[All Fields] OR “Middle East respiratory
syndrome”[All Fields].
5We use the legacy, peer-reviewed journal articles for consistency from the
“PubMed” interface option. The “PMC” option has more content, including
preprints, many lacking metadata indexing and some full text that does not
combine well with analyses of abstract records.
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they combined related articles retrieved from WoS and Scopus
by the same search strings. Slightly different from the above,
Zhang L. et al. (2020) concentrated their study on COVID-19
by a comparison with four selected viruses (e.g., Zika, H1N1,
SARS, and Ebola), and they collected their COVID-19 data
from WoS, PubMed, and CNKI (Chinese National Knowledge
Infrastructure) in the early days of the crisis, with∼3,000 hits.
We post these search results relating to this core COVID
search on the website: http://www.techminingforglobalgood.org/
open-covid-19-research-for-analysis/, as a VantagePoint file.
That text analytic software (VantagePoint) is available for users
to apply to answer their research questions using these data.
The Supplementary Material includes a screenshot
(Supplementary Figure 1) of the VantagePoint summary
sheet describing July 1, 2020, a data file of 47,607 abstract records
of publications indexed by PubMed. Those include 36,184
journal articles (76%). Some points of note as the following:
➢ Some 50 additional data fields can be readily imported to
augment the fields shown; see screenshot [e.g., “Abstract
[Natural Language Processing (NLP)] (Phrases)”].
➢ Various fields can be examined as separate lists or combined
as a matrix to explore relationships.
➢ Elements can be extracted from fields (e.g., countries from
author affiliations).
➢ Cleaning and consolidation can be performed (e.g., fuzzy
matching and stemming from consolidating topical terms,
applying thesauri to remove many unhelpful terms).
➢ Groups of items can be formed and used to form new fields
(e.g., bunching publication dates into three time periods).
To illustrate “zoom in” capabilities, Supplementary Figure 2
shows a screenshot of a “sub-sub-sub-dataset.” We first separate
the 29,156 COVID-19 PubMed records dated 2020. We then
apply a thesaurus that separates affiliations into their most likely
category of academic, corporate, government, and/or hospital—
creating a sub-dataset of the hospitals. We then separate the
699 records with hospital affiliations with a US location. The
screenshot spotlights the 43 publications with a Brigham and
Women’s Hospital author or co-author. The five titles by
Meissner are highlighted. The detail windows on the right
show high-frequency topics covered by the 43 articles—MeSH
Descriptors, terms related to the eight factors pertaining to
tactical vs. strategic emphases, and NLP-extracted terms. In
essence, the data are thereby made accessible to begin to identify
one’s interests therein.
For our several analyses, we categorize publication dates6 in
several ways. We do so to focus more suitably on particular
analytical inquiries. These include the following7:
6For some of our analyses, we approximate month of publication. The PubMed
“date published” field contains various details—e.g., “2020 June,” “2020,” “2020
June 1,” “2020 Summer,” “2020 Sep–Oct,” etc. Furthermore, publication dates are
uncertain with different policies on dating digital and print versions, journal issue
“pre-dating,” etc. So our dating is approximate.
7We calculate emergence using 10 time periods from September 2019, through
June 2020.





1 Univ of Hong Kong 547 157
2 Huazhong Univ of S and T 425 393
3 Chinese Univ of Hong Kong 400 112
4 Chinese Acad of Sciences 311 91
5 Wuhan Univ 298 239
6 Univ of Pennsylvania (2) 268 115
7 Utrecht Univ 241 30
8 Johns Hopkins Univ 240 141
9 Univ of Toronto 220 107
10 Nat Univ of Singapore 214 136
11 Univ College London 211 183
12 Univ of So. Cal. 211 30
13 Fudan Univ 210 129
14 Univ of California 206 50
15 Univ of North Carolina 198 38
16 Chinese Acad of Med Sci 190 120
17 Univ of Iowa 190 34
18 Univ of Washington 182 131
19 Chinese Acad of Agri Sci 181 14
20 Ohio State Univ 164 31
21 NIAID 158 44
22 Ministry of Health, Saudi Arabia 139 38
23 Tan Tock Seng Hospital 114 57
24 Nat Inst of Infectious Diseases, Japan 105 6
25 Univ of Georgia 105 1
➢ Tables 1, 4 compare the entire period (47,607 articles) to
2020 publications.
➢ Figure 4, as well as Supplementary Figure 3, track topical
evolution for the entire period, 1949 through 2020 (part-year).
➢ Table 3 compares two periods: 1949–2019 (“historical”) vs.
2020 (to date, the search conducted on July 1) to sharpen
perspective on topical emergence.
➢ Figures 1, 2 accentuate evolving disciplinary contributions
for monthly COVID-19 periods, from January 2020.
➢ Figures 5, 6, like Figure 2, focus on the COVID-19 era of
2020 publications.
Figure 3 and Supplementary Figure 1 offer a glimpse of fields
available for various analyses. As we have done biweekly data
downloads and analyses starting March 25, 2020, we have
refined the raw data various ways. To anticipate the “4W’s” of
section Results Part 1: COVID-19 Research Profile, we note basic
cleaning in VantagePoint includes the following:
➢ Who? Particularly consolidate author organizational name
variations using a combination of COVID-19 dataset
8PubMed distinguishes 62 types of publications in the dataset, led by journal
articles (76%).
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FIGURE 1 | Growth in COVID-19–related Publications Indexed by PubMed, Monthly, January-June, 2020.
affiliation names in a continually growing thesaurus, along
with a List-Cleanup fuzzy matching routine tailored to
PubMed data formatting9 —e.g., to extract from “Department
of Radiology, Union Hospital, Tongji Medical College,
Huazhong University of Science and Technology, Wuhan,
Hubei, China.” “Huazhong Univ of S&T”
➢ Where? Author country location extracted from strings such
as that just given, leading to building of a COVID-19–oriented
thesaurus to clean further (e.g., to ensure “PR of China”
appears as China, not Puerto Rico too).
➢ When? The challenge posed by COVID-19 data analyses is
their unprecedented pace. We are used to handling annual
publication dates. However, we sought something finer here.
We explored various of the eight or so provided dates—e.g.,
Entrez Date, Date Created, but deemed Date Published as
most effective. While recognizing that monthly dates are not
fully accurate reflections of research timing, we use these in
analyzing topical emergence. To consolidate at a monthly
level, we have built a date thesaurus. For instance, this would
tag as “2020.06 (June)” such variations as 2020 Jun, 2020 Jun
1, 2020 Jun 25, 2020 Summer, 2020 Jun/Jul, etc.
➢ What? As discussed in section “What?” we address multiple
topical resources that pose multiple data quality issues. MeSH
terms, as indexed by NLM, are invaluable, but MeSH indexing
of recent month publications lags. Ying Huang devised an
approach to consolidate related topics across four levels that
9To address the challenges of PubMed affiliation variations, the VantagePoint List
Cleanup (using “Extract main”) script incorporates regular expressions (regex) and
particular fuzzy matching routines.
facilitates topical analyses using MeSH. Abstracts are available
for some 65% of the record set. We extract phrases from
titles and abstracts using VantagePoint NLP that is tailored
to scientific discourse10,11. We apply a routine with multiple
thesauri (e.g., “scientific & academic stopwords”; “common
& basic stopwords”)12; and a fuzzy matching List-Cleanup
routine to consolidate phrase variants. For certain analyses,
we combine these NLP phrases with MeSH Descriptors or
Level 3 terms.
RESULTS PART 1: COVID-19 RESEARCH
PROFILE
We first overview the “Who? Where? When? What?” of
this explosively growing research literature [e.g., our biweekly
updates, using the standard NLM historical and COVID-
19 search query have grown from 19,538 publications on
10The VantagePoint NLP is based on the Princeton WordNet approach for Part of
Speech (PoS) tagging, but its noun phrase extraction differs as it is tailored to keep
scientific and technical terms intact (e.g., chemical formulas).
11VantagePoint software, and the related Derwent Data Analyzer from Clarivate,
focuses primarily on aiding analyses of research publication and patent abstract
record compilations. It has been applied in many studies, particularly in
conjunction with “tech mining” (Porter and Cunningham, 2005). Explorations
of its algorithms, applications, and assessments can be found in conjunction
with the annual Global Tech Mining (GTM) conferences—https://vpinstitute.
org/global-techmining-conference/global-techmining-conference-2020/—and in
some hundred or so papers on the VPI website—https://vpinstitute.org/.
12Compiled over years from multiple resources and empirical results (e.g., by
running a list cleanup routine and saving matches to a thesaurus).
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FIGURE 2 | Medical Subject Headings (MeSH term) Distribution Consolidated to 4 Levels.
March 25, 2020, to 47,607 on July 2 (used in the present
analyses), and 70,193 as of September 6]. Haghani and Bliemer
(2020) and Thelwall (2020) conducted the case that historical
research bears importantly on current COVID-19 research. Such
profile information should facilitate identifying and locating
key players and their research foci. That intelligence, in turn,
can help identify research topics to consider oneself, key
sources, and potential collaborators. It may also stimulate more
detailed inquiries one might pursue. To set the stage, here are
select “4W” basics.
The 4 W’s: Who? Where? When? What?
This section profiles prominent features of the COVID-19
research landscape to gain perspective on research players and
trends based on the core PubMed dataset downloaded on July 1,
2020 (47,607 records).
Who?
These 47,607 published articles are authored by a strikingly
broad array of researchers (150,000+), organizations (after basic
cleaning, 5,819 with multiple publications), and countries (191).
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FIGURE 3 | Screenshot of VantagePoint Software: Exploring Combinations of Who, Where, When, and What?
We treat countries under “Where?” and we leave the individuals
for exploration on the website (7,296 with five or more articles in
the dataset).
Table 1 lists the Top 25 organizations for this dataset,
coinciding with >100 articles13. The rightmost column shows
how many of those articles appeared with 2020 dates. Note
that research emphases shift sharply—e.g., #25, the University
of Georgia, has not been very active this year. Conversely, #2,
Huazhong University of Science & Technology, which is in
Wuhan—the central city of the early COVID-19 pandemic, has
been more active this year (only 32 pre-2020 articles vs. 393 so
far this year). Such shifts reflect the transition from study over
decades of coronaviruses and the SARS and MERS outbreaks, vs.
COVID-19 pandemic–motivated studies.
The USA (with 10) and China (8, including Hong Kong)
dominate this list of top organizations.
13Affiliation information in PubMed is somewhat varied. These values reflect
matching of items, but not in full detail. We combine units (e.g., hospitals) with
their primary organizations (e.g., universities).
Again, anyone interested in details is invited to visit our
websites to explore the dataset.14 Information such as the
following is available:
➢ Ability to search for a particular organization’s or an author’s
publications in the 47,607 set;
➢ Topical emphases by particular players using Medical Subject
Heading (MeSH) Qualifiers or Descriptors, or title and
abstract phrases;
➢ Connections among players (e.g., maps or matrices of who
collaborates with whom).
Where?
The 47,607 articles in the dataset are associated with 196
countries. Of those, 12 appear as author affiliations on >1,000
articles; 45 have >100. Two city–states are in the top 20—
Singapore and Hong Kong. The leading two countries are the
14See the links: https://www.researchgate.net/project/COVID-19-Research-
Literature-Profiling-and-Mining; and http://www.techminingforglobalgood.org/
open-covid-19-research-for-analysis/.
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USA (9,843) and China (7,400). We are interested to see Top 20
contributions from Iran (613) and Saudi Arabia (613) and note
Saudi—the initial center of MERS pandemic—interests in MERS
have continued actively since 2014.
➢ USA−2,874 of 9,843 articles (29%) show international co-
authoring, most with China (729)
➢ China−1479 of 7,400 articles (20%) show international co-
authoring, most with the USA (729)
[China–USA collaboration remains strong in most recent
months, despite political forces−13% of 1,550 Chinese articles
dating June or beyond are joint with US authors, compared
to 8% of Chinese COVID-19–related publications prior to
May. This finding coincides with that observed by Fry et al.
(2020)—the COVID-19 crisis accelerates the international
collaboration in and between China and the USA].
➢ Italy−1,223 of 3,635 articles (34%) show international co-
authoring, most with the USA (453)
➢ Extensive European co-authoring among some 20 European
countries in the Top 45.
When?
The trend in COVID-19–related research is astounding. A plot of
the time series from 1949 through 2020 (part-year) appears in the
Supplementary Material, see Supplementary Figure 3. Growth
is hyper-exponential.
Academia can often respond quickly to public health
emergencies. We see a sharp increase in the number of
publications immediately following the declaration of an
outbreak by the WHO. To estimate the recent COVID-19
research growth, we divide the publication dates into months
from September 2019 through “June on,” 2020.15 Figure 1 plots
the monthly data from January 2020 [For the last 4 months of
2019, the count is mostly flat, ranging from 58 to 78 articles
indexed by PubMed]. That more than doubled in January, and
again in February, and tripled in March, and again in April.
The proportionate rate of growth calmed somewhat, doubling
from 4,459 publications in April to 8,985 in May, then increasing
somewhat less (by 3,431) to June (on)’s 12,416. However, in
perspective, we have gone from fewer than 100 articles/month to
more than 12,000 per month in less than a year.
What?
A prime reason to compile COVID-19–related research is to
discover research knowledge that can be brought to bear in
helping to remedy the pandemic and prevent or mitigate future
ones. Toward such ends, we aspire to make the topical content
accessible and relatable to one’s research questions.
The 47,607 abstract records from PubMed offer several topical
information resources:
➢ Titles (for 99% of the records)
➢ Abstracts (for 65%)
15These are approximate given the vagaries of publication dating. In our download
on July 1, we have 2,503 publications dated beyond June. For these analyses, we
include them in “June on.”
➢ MeSH indexed terms (for 56%), including Qualifiers (76
categories found for this dataset), Descriptors (9,412), and
Primary Terms (27,174)
To enhance those, we have several derived topical fields:
➢ VantagePoint extracted NLP phrases or words from Titles
and Abstracts
➢ Merged fields, especially “Combo NLP” made of Abstract
NLP phrases and Title NLP phrases and MeSH Descriptors
combined [each field and the combined field having been
refined using a combination of stopword thesauri and fuzzy
matching routines (“Refine NLP” script in VantagePoint)]—
to yield 392,247 terms (covering 96% of the records to
some extent)
➢ Emergent terms (phrases) evidencing accelerating recent
growth (1,380) (how these are calculated is discussed shortly)
We provide select top-level synopses to gain perspective on this
topical content. Figure 2 illustrates the complexity of the MeSH
hierarchical index terms, showing the top three levels. On the
one hand, some related concepts are listed in multiple levels—
e.g., “severe acute respiratory syndrome (SARS)” (Unique ID:
D045169) is allocated to three sub-fields (Tree Numbers) at two
different levels:
➢ C01.748.730 (Level 4) under “respiratory tract
infections [C01.748]”
➢ C01.925.782.600.550.200.750 (Level 8) under “coronavirus
infections [C01.925.782.600.550.200]”
➢ C08.730.730 under “respiratory tract infections [C08.730]”
On the other hand, an article might be indexed with several
MeSH terms—e.g., The article “Localization of mouse hepatitis
virus open reading frame 1A derived proteins” (PMID:
10065901) has Primary MeSH terms (no subheading):
➢ DNA, viral ([D13.444.308.568])
➢ Murine hepatitis virus ([B04.450.580]
and [B04.820.578.500.540.150.113.875])
➢ Open reading frames ([G05.360.335.760.640],
and [G05.360.340.024.340.137.650])
➢ Viral proteins ([D12.776.964])
Therefore, we cannot compare them to tally high-frequency
MeSH terms directly. So, we set out to consolidate the lower
level items to the upper level. When we want to analyze them
on Level 4, the Tree Number of the article mentioned above
can be presented as D13.444.308, B04.450.580, B04.820.578,
G05.360.335, G05.360.340, and D12.776.964. So, we determined
to consolidate related terms at different levels by using a
thesaurus to group related MeSH terms.
In terms of the MeSH hierarchy, we can follow the
tree structure up or down. For example, going downward,
Level 1 (single letter) includes diseases [C]. Under that at
Level 2 (letter–number), one category is infections [C01].
Under Infections, at Level 3 is virus diseases [C01.925].
Under virus diseases at Level 4 is RNA virus infections
[C01.925.782]. Coverage can be impressively extensive. For
instance, in this core COVID-19 dataset, more than half the
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TABLE 2 | COVID-19 topics (top 16 MeSH Qualifiers) by country (top 12), for all years (47,607 records).
Records 9,843 7,400 3,635 3,548 1,851 1,716 1,538 1,416 1,159 1,134 1,096 1,044
Records MeSH qualifiers USA China Italy UK Canada France Germany India Australia Spain The Netherlands Japan
8,704 Epidemiology 13.9% 19.1% 14.2% 17.9% 20.5% 16.6% 12.8% 14.0% 19.8% 10.6% 13.7% 14.8%
8,051 Virology 20.5% 22.5% 10.3% 11.3% 14.5% 14.1% 20.6% 7.6% 14.7% 10.0% 25.9% 32.5%
6,821 Genetics 16.4% 20.2% 5.2% 8.3% 13.0% 10.7% 18.8% 4.6% 9.8% 12.9% 29.9% 25.6%
5,252 Immunology 12.2% 13.2% 4.3% 5.6% 11.2% 7.1% 10.7% 2.6% 6.0% 9.3% 14.5% 21.1%
5,058 Isolation and purification 8.7% 12.7% 6.2% 6.3% 9.5% 8.6% 10.2% 4.2% 8.6% 4.8% 11.1% 15.8%
5,054 Prevention and control 10.2% 9.9% 6.6% 10.5% 13.8% 7.9% 7.9% 7.9% 12.3% 6.0% 9.8% 9.1%
4,106 Metabolism 11.9% 11.7% 2.5% 4.7% 8.4% 6.8% 16.7% 3.5% 2.6% 8.1% 21.4% 16.2%
3,981 Diagnosis 6.1% 11.6% 6.5% 6.7% 6.9% 7.8% 8.3% 4.6% 6.5% 4.8% 6.0% 8.0%
3,734 Methods 7.8% 9.4% 5.8% 7.2% 9.6% 6.0% 7.6% 5.9% 8.4% 5.5% 8.2% 8.7%
3,385 Veterinary 6.9% 6.4% 3.9% 4.3% 4.4% 4.0% 4.8% 1.4% 6.0% 3.4% 7.8% 16.2%
3,074 Physiology 9.9% 6.3% 1.9% 3.7% 7.1% 5.8% 10.2% 2.7% 3.5% 6.7% 16.9% 14.2%
2,829 Transmission 5.1% 7.0% 4.0% 6.1% 6.4% 5.2% 5.1% 3.5% 6.9% 2.8% 5.9% 4.0%
2,481 Pathogenicity 6.7% 6.1% 2.6% 2.6% 4.9% 3.1% 6.6% 2.5% 3.4% 4.7% 7.9% 10.9%
2,377 Chemistry 7.1% 7.4% 1.4% 2.4% 4.2% 4.1% 9.0% 2.5% 1.6% 5.7% 9.2% 9.4%
2,341 Therapy 4.5% 6.6% 6.5% 5.4% 5.7% 6.2% 5.1% 3.7% 5.6% 4.6% 3.1% 2.1%
2,156 Pathology 5.6% 5.8% 2.3% 1.7% 5.2% 2.8% 3.8% 2.2% 2.6% 1.9% 5.1% 8.8%
records (24,796) are associated with that Level 4 topic—RNA
virus infections.
From Figure 2, we see that the virus diseases [C01.925] in
infections [C01], and RNA viruses [B04.820] in viruses [B04]
are the most common MeSH topics (sub-fields) in this COVID-
19 dataset. Those are followed by respiratory tract diseases
[C01.748, C08.730], a converged sub-field in the above two
fields. Besides, lung diseases [C08.381], public health [N06.850],
and proteins [D12.776] are three other notable sub-fields in
COVID-19 research. Overall, the diseases [C] cover the most
records, followed by organisms [B], chemicals and drugs [D], and
healthcare [N] in Level 1. The Top PrimaryMeSH terms in Levels
2 to 4 for these COVID-19 core publications set are shown in
Supplementary Tables 1–3.
We explore “emerging topics” —a particular subset of topical
information of high potential value—in section Results Part 2:
Special Analyses.
4W’s in Combination
Combinations of the Who, Where, When, and What factors
offer insights into research concentrations. Select comparisons
have appeared in section The 4 W’s: Who? Where? When?
What?—e.g., emergent topics shifting over time. We present a
few combinations here and invite exploration of one’s particular
interests on the website.
Table 2 breaks out topics using the top 16 MeSH Qualifiers
(>2,000 associated records) by the top countries, showing
the percentage of a country’s articles that address the given
topic (for all years in the dataset). Research policymakers or
managers might be interested in relative emphases, as these
topics correspond somewhat to disciplines. For instance, Japan
shows the highest concentration on virology (32.5%), with India
the least (7.6%). Genetics and immunology are less emphasized
in India, Italy, and the UK, but more in the Netherlands
and Japan. Or, one could scan by country, noting that Japan’s
emphases seem somewhat different on multiple categories (e.g.,
the highest percentage on some nine of these domains). Or one
might compare particular countries—the USA and China appear
to hold generally similar research interests regarding COVID-
19. Similar breakouts of topical categories by organization or
author enable detailed exploring for expertise focused on one’s
intersection of interests.
Crossing topics by topics facilitates the identification of
important confluences. This is likely to yield valuable intelligence
at quite specific levels. A matrix of the 29 emergent topics
by the 29 emergent topics could provide useful leads. To
illustrate, within this dataset of COVID-19–related articles,
someone pursuing immune system attributes might be especially
interested in the seven articles considering T cells and
immunoglobulin M.
Three (or more) dimensional combinations can also be highly
informative. We do not attempt to show many of those here,
but the website enables tailored exploration. Just to illustrate,
we separate the 304 of the 47,607 COVID-19–related records
concerning T cells. Then, we select the subset of 45 records,
also considering D-dimer (relevant to diagnostic testing for blood
clotting). The screenshot (Figure 3) shows the selection of the
26 of those published since May 2020. The window on the left
gives the article titles. The detail windows on the right show
the following:
➢ This research is concentrated in China, especially at
Huazhong University of Science and Technology, with many
authors (no high concentration in one person who might be
the laboratory leader).
➢ It relates mainly to pneumonia, especially with middle-
aged persons.
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Probing a little deeper, can we tell who might be key researchers
on the topic at Huazhong? The six articles show 137 authors.
Mapping just those co-authoring two of the articles, we see two
groups: Li and Hu, and Wu, Ning, and Luo. So, if we want to
pursue, we might read the abstract records of each and possibly
do further research by finding the full articles to read.
RESULTS PART 2: SPECIAL ANALYSES
Emerging Topics in COVID-19 Research
We score terms appearing in the titles and abstracts on the extent
to which they are “emergent” —i.e., terms evidencing increasing
attention in most recent periods (Carley et al., 2018; Porter et al.,
2018). This notion of emergence builds upon the research of the
US Intelligence Advanced Research Projects Activity (IARPA)
Foresight and Understanding from Scientific Exposition (FUSE)
Program.16 Our contributions to IARPA FUSE conceptualization
appear in Alexander et al. (2012). FUSE explored full text datasets
and entire databases. Our adaptation is to devise emergence
indicators using targeted datasets (e.g., on a particular scientific
or technological domain), using abstract record sets (Carley et al.,
2018; Porter et al., 2018; US Patent Application 15/803,185).
We draw heavily upon Rotolo et al. (2015) who digest
extensive conceptual contributions and empirical research
bearing on technical emergence. We set thresholds on
four factors:
➢ novelty [appearing in <15% of base period (first three
periods—here, those are September, October, and November
2019) records],
➢ persistence [term appears in at least seven records, in at least
three periods],
➢ community [at least two organizations using the term in
the corpus],
➢ growth [term usage grows at least 1.5 times the overall
publication growth rate in the dataset being analyzed].
Porter et al. (2018) provide a series of empirical studies that,
along with additional studies, contribute to these thresholds
for the indicators. By and large, these are based on empirical
judgments based on a moderate number of case analyses and
consensual opinions by the developers, not strong theoretical
foundations. For novelty, allowing a small number of occurrences
of a topical term in the base period, rather than zero, retains
topics that take a few periods for uptake. Persistence thresholds
seek to sidestep one-shot wonders. For community, we seek
to avoid singular topics by requiring authorship from more
than a single organization. Scope entails consideration of term
Inverse Document Frequency (IDF) values to prescreen terms
less domain-specific. The growth threshold seeks to distinguish
emerging topics in fast-growing domains—especially pertinent
to COVID-19–related research. Calculating the tech emergence
indicators is facilitated via a VantagePoint routine. That macro
offers one the opportunity to vary these parameters. One can
apply additional ones as well; notably, “scope” can be narrowed
by using IDF to screen out terms very common in the dataset.
16See the website: http://www.iarpa.gov/index.php/research-programs/fuse.
The script then derives an Emergence Score for each term by
weighing three growth rate measures—active trend (change in
publication rate from periods 4–6 to 8–10), recent trend (change
from periods 7–8 to 9–10), and slope (change in rate from
period 7–10). This formulation derives from the oft-observed
“S-shaped” growth of emerging technologies. Assessment of the
tech emergence indicators suggests interesting potential to help
anticipate future research directions and innovation potential
(Kwon et al., 2019; Porter et al., 2020). The hyper-exponential
growth of COVID-19 research poses a different model (grounds
for future research).
Emergence Scoring has been developed using years to
constitute 10 time periods. Our algorithm divides those into
the first three as a base period and the last seven as the
active (growth) period (Porter et al., 2018). We have adopted
this model for particularly fast-growing domains by trying
shorter periods—especially using half-year research publication
or patent filing periods. COVID-19 challenges this emergence
model because of its hyper-growth in 2020 (Figure 1 and
Supplementary Figure 3). So, to operationalize recent periods,
we made 10 groups of records based on publication month,
dating from September 2019, through June (on), 2020 (see
Figure 1 for the 2020 months). Still, the extreme variation
therein (from about 80 articles per month to over 12,000 per
month) represents a new venue in which to apply our Emergence
Scoring method.
We ran VantagePoint’s Emergence Scoring script on the
“combo NLP” field of 392,247 terms to spotlight 1,380 Emergent
Terms17. We then clustered those terms based on their tendency
to co-occur in records of the dataset, using VantagePoint’s “factor
mapping” script that applies a tailored version of principal
components analysis (PCA) (Wang et al., 2019).
Table 3 lists the resulting emerging topics and the number of
records in which their high loading terms (that constitute each
topical cluster) appear.18 The PCA routine names the factor for
its highest loading term. We edit some of those names—e.g.,
“patient care teaming,” rather than “pharmacy service, hospital.”
That factor has four additional high-loading terms (infection
control, intensive care units, health services needs and demand,
and interdisciplinary communication); we feel “patient care
teaming” better characterized the group of terms.
These topics spotlight current research priorities to stimulate
consideration of one’s research emphases as a researcher or
research manager. The topics offer what we believe is an effective
granularity (vs. the more detailed 1,380 emergent terms or the
overall categorizations of Supplementary Tables 1–3).
The right two columns of Table 3 display the percentage
of records in the period before 2020, and those in 2020 as
of July 1, associated with each emergent (“hot topic”) group.
The most prevalent, “patient care teaming,” holds pretty steady,
from 3.3% of the pre-2020 articles that include at least one
of its six high loading terms, to 2.9% that do so in 2020
17We refined the resulting 1,380 Emergent Terms to 1,347 by culling 33 very
general terms appearing in many records (e.g., COVID-19), locations (e.g.,
United Kingdom), or less interesting terms (e.g., illness).
18Leaving out a few with minimal substantive interest—e.g., “# of patients” —and
consolidating two variants of ACE2.
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TABLE 3 | COVID-19–related research emergent topics.
Emergent topic groups Records 1949–2019 2020 (through
July 1)
Patient care teaming 1464 3.3% 2.9%
Intensive care unit 1414 1.6% 3.9%
Personal protective equipment 1409 2.2% 3.5%
Symptoms (e.g., fever) 1364 2.2% 3.3%
Computed tomography 984 0.7% 2.9%
C-reactive protein (e.g., d-dimer) 820 1.1% 2.5%
Angiotensin-converting enzyme 2 950 1.3% 2.0%
Diabetes 797 0.4% 2.5%
Hydroxycholoroquine 736 0.2% 2.4%
Surveys and questionnaires (health
knowledge, attitudes, practice)
663 1.8% 1.2%
Cancer 630 0.4% 1.9%
EMBASE 628 0.4% 1.9%
Mental health 535 0.3% 1.7%
Study protocol (e.g., randomization) 532 0.9% 1.2%
Healthcare disparities (inequities) 492 0.2% 1.5%
Surgery 357 0.1% 1.2%
Anticoagulants (thrombosis) 352 0.1% 1.1%
Ritonavir/lopinavir 319 0.2% 1.0%
Infectious disease transmission, vertical
(pregnancy)
308 0.5% 0.8%
T cells 304 1.3% 0.2%
Antibodies (IgM, IgG) 303 1.0% 0.4%
Arrhythmias 259 0.1% 0.8%
Education, medical 220 0.1% 0.7%
Olfactory disorders (anosmia) 212 0.0% 0.7%
Neurological manifestations 212 0.2% 0.6%
Molecular docking 183 0.3% 0.4%
Head and neck neoplasms 176 0.1% 0.6%
Orthopedics 148 0.0% 0.5%
Ophthalmology 112 0.0% 0.4%
articles. A number of the topics show the strong escalation of
interest in 2020, including the following whose percentages at
least tripled from the pre-2020 historical period to the 2020
COVID-19 era:
➢ medical issues other than respiratory system (olfactory
disorders, ophthalmology, surgery, head and neck neoplasms,
orthopedics, arrhythmias, anticoagulants, diabetes, mental
health, cancer, neurological manifestations)
➢ antivirals (hydroxychloroquine, ritonavir/lopinavir)
➢ computed tomography (CT)
➢ socioeconomic facets (healthcare disparities,
medical education)
Some topics show considerably less attention as a percentage of
articles in 2020 compared to pre-202019:
➢ social facets (surveys and questionnaires)
19These are all “emergent” topics based on strong growth in attention over the
months from September 2019 through June, 2020. Table 2 shifts this comparison
extending back in time from 1949 onward.
➢ immune system facets (antibodies, T cells)
Were one inclined to pursue research on one or more of
these emergent topics, the records associated with a given
topic (e.g., the 112 addressing an aspect of Ophthalmology
regarding COVID-19) could be separated for further analyses
(e.g., identifying who is authoring and what related topics they
are considering). We are working to develop the noted website20
to enable users to do such “zooming in” without needing
the software.
Tactical vs. Strategic Topic Focus:
Empirical Exploration of COVID-19–Related
Research
Ron Kostoff and colleagues make a vital case: The COVID-19
pandemic is not merely caused by a particular virus (SARS-
CoV-2) operating in a vacuum; rather, the disease’s consequences
reflect how individuals’ immune systems interact with that virus
(Kostoff, 2020). To a striking degree, certain demographic groups
(the elderly and those with weakened immune systems) are
highly vulnerable, whereas others (healthy younger cohorts)
are nearly invulnerable. That calls into question which societal
policies and approaches would best counter the pandemic
(Kostoff et al., 2020a,b).
Here, we explore how some terms associated with particular
approaches show forth in the COVID-19 research literature.
Following Kostoff (2020), we distinguish two types of approaches:
tactical (virological—focused on stopping the target virus now)
vs. strategic (toxicological—focused especially on strengthening
immune systems), along with categories of actions pertaining
to each:




➢ strategic (toxicological orientation)
◦ lifestyle factors
◦ iatrogenic factors (side effects of medical treatments—





We searched for some 125 terms (a few with contingencies—
e.g., chronic stress and immune∗) and located some 86 in
the 47,607 abstract records21. Supplementary Table 4 in the
20https://www.researchgate.net/project/COVID-19-Research-Literature-
Profiling-and-Mining.
21Some of the terms, particularly some associated with lifestyle (e.g., substance
abuse) and psychological/social/economic (e.g., aspects of stress), may appear
in COVID-19-related research literature as causal factors diminishing immune
system health, but also as effects of the pandemic and its treatment. This prompts
consideration of specifying contingencies to separate the immune health aspects
that are of most interest here.
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3,290 Vaccination 2,415 875 0.36
2,120 Restrict exposure 351 1,769 5.04
1,183 Antiviral medications 211 972 4.61
1,028 Biotoxins 935 93 0.10
992 Iatrogenic 368 624 1.70
801 Lifestyle 256 545 2.13
159 Occupational/environmental 80 79 0.99
6 Psychological/social/economic 3 3 1.00
Supplementary Materials lists those found, together with their
categories of action. Table 4 breaks out frequencies of occurrence
pre–COVID-19 (i.e., through 2019) vs. in COVID-19 times
(i.e., 2020 publication dates). For instance, of the 3,290 records
pertaining to vaccines, 2,415 have publication dates pre-2020; 875
are dated 2020. So the ratio of 2020 to pre-2020 is only 0.36.22
Patterns of occurrence are intriguing. Note that the 1949–2019
dataset reflects 39% of the total 47,607 records; the 2020 data,
61%, albeit concentrated in a very short span of some 6 months.
The ratio of 2020/pre-2020 articles is 1.58. That said, some points
of interest are as follows:
➢ Vaccine focus in 2020 is relatively less than previously.
➢ Focus on the other two tactical (virological) categories is
way up.
➢ Focus on the strategic (toxicological) categories is
relatively steady.
These tabulations suggest that the major focus of 2020 research
has been on virological approaches under the duress of
the pandemic. Attention to both restricting exposure and
antivirals is up about 5-fold. Further, we know that attention
to vaccine development is high, but the nature of that in
the compressed 2020 timeframe, with proprietary and clinical
trialing considerations, may suppress its consideration in the
open research literature. One might imagine considerable
attention being directed to vaccine safety, but a search of the
47,607 abstract records spots only 36 mentioning that phrase.
On the other hand, attention to the more strategic approaches
oriented to bolstering immune systems is not absent, but neither
is it up proportionately.
Topic Evolutionary Pathways
Zhang et al. (2017) have developed an approach of SEPs to track
the evolution of topical emphases over time (In the original
algorithm, they define a topic as a group of similar articles and
geometrically represent it as a circle, with a centroid measured
by the mean of all involved articles, and a boundary measured by
the largest Euclidean distance between the centroid and all other
22We compare differences for this set of publications; we do not apply statistical
significance testing to these differences to infer to other datasets.
articles). The algorithm then categorizes articles published in one
time period (e.g., a year), and thus, the entire dataset is analyzed
as a bibliometric stream. Along the stream, SEP processes articles
one by one—assigning each article to its most similar topic,
and based on the Euclidean distance between an article and
the centroid of its assigned topic, deciding whether this article
belongs to the exact topic (i.e., the distance is within this topic’s
boundary) or a sub-topic (i.e., the distance is larger than the
boundary, indicating a potential drift of knowledge occurs).
Then, the relationship between the topic and its sub-topics is
defined as a predecessor–descendant relationship—the key to
understanding the evolution of topics. Besides, the algorithm
labels a topic as the term sharing the highest average similarity
with all other involved terms, but if such a term has already been
used for labeling, it will use the second one, and so forth.
We configured the bibliometric stream with the following
strategy, and in total, we set 26-time slices for the COVID-
19 case:
1) We grouped articles published between 1949 and 1980 as
the initial topic of the evolutionary pathways and label as
“coronavirus.”
2) The following two time slices respectively cover articles from
1981 to 1990, and from 1991 to 2002, since a rapid increase
in the number of articles occurred in 2003 due to the
SARS pandemic.
3) From 2003 to 2019, each year is set as a time slice; and
4) We divided the data of 2020 into months, and thus, six time
slices are obtained.
Figure 4 presents a complex developmental profile for the
47,607 COVID-19–related research articles, which could help
gain perspective on topical heritage in at least four ways.23
For one, a reader can locate a topic of recent interest and
observe its associations with prior research topics. To illustrate,
toward the center–right edge, we note a recent emphasis
in June 2020, on “rapid spread.” That draws upon work
on infectious diseases, in turn nucleated by studies about
Wuhan (February 2020).
A second approach is to step back and note some 10 color-
coded concentrations of research, which is generated by the
approach of community detection integrated into Gephi as
“modularity” (Newman, 2006). Large nodes (node size indicates
the number of studies) that appear to nucleate various ongoing
research threads include (moving from left to right in Figure 4)
epidemiology, infectious bronchitis, murine coronavirus, SARS
CoV, reverse transcriptase–polymerase chain reaction (RT-PCR),
Wuhan, influenza, and MERS CoV.
Third, digging into these research threads can help locate
one’s own, or others’ research emphases, possibly suggesting
information resources worth mining. One can then examine
related research threads of particular interest. Some could include
the following:
23Note that in Figure 4 each node represents a research topic, and an arrow
represents the pre-decessor-descendant relationship between its connected nodes,
and the thickness of an arrow then indicates the strength of such a relationship.
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FIGURE 4 | Topic Evolution Pathways in COVID-19 Research [based on analyses of the 47,607 core PubMed search as of July 1, 2020].
➢ Early coronavirus research conducted before 2003 seems
mostly related to murine coronavirus. After 2003, topics
within this thread establish the foundation of coronavirus
research, especially in molecular virology, such as the
viral genome, spike protein, and RNA virus. Thus, after
the COVID-19 pandemic, new paths, including clinical
characteristics (e.g., immune response and Cytokine
Strom), testing approaches (e.g., CT images), and vaccine
development, might uncover certain key knowledge bases of
testing, treating, and preventing COVID-19.
➢ SARS studies, from 2003, as the year of the SARS
pandemic—the first human coronavirus outbreak recorded
after the Millennium—provide roots extending out several
paths to certain common features of COVID-19, such as
interspecies transmission and fever. Two highlights are
observed along with this thread: concerns in the healthcare
system (maybe especially for the United States) during April
and May 2020, and tocilizumab, a drug considered for
COVID-19 treatment.
➢ RT-PCR (from 2006) displays half a dozen or so threads,
including diagnostic testing links to SARS, branches for
different types of coronaviruses, and strong association with
influenza research. It is not surprising that at the early stage
of the COVID-19 pandemic, compared to virologic research,
public health issues, closely linked with protection, control
measures, testing, and early detection of COVID-19 are raised
by, not only the general public but also academia. Besides that,
topics such as emotional distress and psychiatric symptoms,
together with Northern Italy, are observed in June 2020
and thereafter.
➢ MERS (2013) ties closely to Saudi studies and South Korea,
highlighting the second human coronavirus outbreak after
SARS, and along pathways involving different demographic
groups. Current concerns could well link back to the
experience of handling the MERS crisis, like social media
and telemedicine.
➢ Wuhan (2020, February) marks the starting locale of the
COVID-19 outbreak, and the size of this node also indicates
the incredible number of articles published in such a short
time. Specifically, this thread tracks to WHO roles and a range
of clinical and public health concerns.
A fourth perspective looks at the degree of connectivity of
particular topics in terms of network analytics. For example,
toward the bottom left of Figure 4, note a separate, small tree
structure emanating from mental health professional concerns.
Or in the upper central region, note a “UK government” node
not connected to other topics at the threshold of the figure.
Examination of the SEP can suggest opportunities for new
connections to bolster the transfer of research knowledge.
Topic connectedness is itself of interest. We calculated the
similarity (degree of relation) among the 109 topics in the map
(Figure 4). Prior to 2020 (i.e., prior to COVID-19 emergence),
this domain showed a level of similarity of 0.12. In contrast, 2020
topics show a lower similarity of 0.03 with topics generated prior
to 2020. Furthermore, the average similarity among active 2020
topics is 0.03 as well. This suggests a relatively weakly connected
research domain. This could reflect the “explosion” of truly novel
research or a hurried research environment wherein full review
of the extant knowledge is not taking place.
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FIGURE 5 | The Extent of Co-authoring among the Top 30 Countries (for COVID-19 papers in 2020). Node size reflects number of papers published, 1949-2020 (to
date, July 2); links indicate substantial degree of co-authoring, shown above a threshold.
The Research Community
This section explores some aspects of the “players” active
in producing these 47,607 journal publications.24 It gingerly
addresses research questions:
➢ How well-connected are the players?
➢ Can we gauge the disciplines contributing?
➢ Does COVID-19 constitute a singular research community?
As mentioned, we see author affiliations in a host of countries—
some 191. To get a sense of the extent of international
collaboration, we mapped international co-authorship in various
ways. Possibly most informative is a look at the top 30 countries
for 2020 publications (each representing >200 articles co-
authored, as of July 1−29,156 of the 47,607 records). Each has
more than 200 articles in the set. Figure 5 shows a VantagePoint
autocorrelation map (country with country). The strongest
connection is among European countries. An especially richly
interconnected core network showing a high proportion of
articles co-authored with four or more other nations includes
the Netherlands, Germany, Belgium, Switzerland, Spain, Austria,
France, and Sweden.
Of note, the leading two contributors have been
preponderantly working alone (not internationally collaborating)
this year:
➢ USA—of 6,101 articles in 2020, 532 with China; 507, the UK,
441, Italy; 339, Canada
24We note that the data are not completely cleaned. PubMed formatting of player
information can be challenging. We developed an improved List Cleanup aid—
“organization names, extract main” —and thesauri to consolidate variations of the
same organization for the COVID-19 data; these helped considerably.
➢ China—of 4,418 articles in 2020, 532 with the USA; 246, UK;
145, Australia; 142, Italy25
A map of the top 20 (each over 100 articles) pre-2020 (18,451
records) is not drastically different. A core European group
collaborates extensively, including the UK. Also connecting
are Saudi Arabia and Egypt. The two leaders show as quite
independent then as well.
Fry et al. (2020) found increased USA–China collaboration
from COVID-19–related research pre-2020 (3.6% of global
articles together) to 2020 research (4.9% co-authored together).
Our data just above find such USA–China collaboration up from
1.1 to 1.8% of global publication totals.
We leave investigation at the organization or individual level
to individuals who could use the website to identify connections
of particular players of interest.
Another community question concerns disciplinary
engagement and interactions. The most direct indicator of
such information from PubMed records is the MeSH Qualifiers.
We explore the extent to which particular of the 2020 records
(29,156) are indexed into various pairs of Qualifiers. We limit
to the most prevalent Qualifiers for this year’s COVID-19 data.
These 19 Qualifiers are associated with between 530 (psychology)
and 4,310 (epidemiology) records.26 On average, these records
show 4.2 of the 19 top Qualifiers. To the extent that these
indicate multidisciplinary:
➢ Most multidisciplinary Qualifiers are pathogenicity (5.0) and
isolation and purification (4.9).
25Here, Hong Kong is treated separately.
26The MeSH Qualifiers are not complete for these data. They are available for only
52% of the 47,607 records. Further, they are present for only 27% of the 2020
publications here. So results are only suggestive of disciplinary interactions.
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FIGURE 6 | MeSH Qualifiers Multidisciplinary Network (for 2020 Records). Node size reflects number of papers associated with the given frequent MeSH Qualifer;
links indicate substantial degree of co-occurrence, shown above a threshold.
➢ Least multidisciplinary are psychology (3.3) and
epidemiology (3.4).
Figure 6 shows the degree of affinity among the top 19 Qualifiers
(those associated with 500 or more articles) for the 29,156 articles
with 2020 dates. Arguably, this shows two clusters27:
➢ Epidemiology centers a network of seven other Qualifiers
that tend to be associated with it (as records are indexed by
National Library of Medicine indexers for MEDLINE).
➢ Virology centers a network of 3 other Qualifiers.
DISCUSSION
Profiling COVID-19 Research
The research enterprise is stressed by the upsurge in research
outputs—Figure 1 and Supplementary Figure 3 offer two
perspectives on the hyper-growth in PubMed-indexed core
COVID-19 journal articles. That is accentuated by other modes
of sharing research results, particularly via preprints (e.g.,
bioRxiv, medRxiv, arXiv). Park (2020) notes the overload on the
peer review system caused by the flood of articles on COVID-19.
Brainard (2020) points out the stress on researchers trying to
keep up with pertinent literature; the outpouring is too excessive
for traditional monitoring and reading approaches to suffice. This
provides an opportunity for research profiling, such as this, to
aid researchers and research managers in identifying valuable
research knowledge.
27The nodes reflect number of records; the links reflect relative degree of co-
occurrence; the map could be drawn to showmanymore links at a lower threshold.
Further, note the limitation of only partial coverage of the record set discussed in
the previous footnote.
We provide high-level tabulations to overview the research
domain—Who? (Table 1); Where? (international collaboration,
Figure 5); When? (Figure 1 and Supplementary Figure 3);
and What (e.g., Table 3)? We offer select combinations
of those aspects—e.g., multidimensional (Figure 3 and
Supplementary Figure 2); and What/When? (Table 4 and
Figure 4). The intent is to orient readers to pertinent
research knowledge, that they might pursue in more detail
via provided web resources (https://searchtechnology.github.io/
VPDashboard/; http://www.techminingforglobalgood.org/open-
covid-19-research-for-analysis/).
We have manipulated “What?” information—i.e., topical
content—in several ways, seeking to depict research patterns
and priorities. These start with the rich MeSH indexing
of PubMed content (c.f., Table 2 and Figure 6 concerning
MeSH Qualifier distribution across leading countries and
Qualifier interconnections). We present ways to compile
MeSH Primary Term topical content across MeSH Levels
(Figure 2 and Supplementary Tables 1–3). We apply Scientific
Evolution Pathways (Figure 4) to identify topics and their
interconnections, showing the evolution over time periods.
Furthermore, Table 3 reports on emerging COVID-19 topics,
whereas Supplementary Table 4 tabulates topical activity
categorized into eight tactical or strategic categories of action
to counter COVID-19. So, we offer multiple, and we hope,
complementary, means to elicit topical intelligence.
It would seem desirable that future research give stronger
attention to the strategic, immune-boosting factors (Table 4).
Recognizing that viral exposures cannot be generally eliminated,
strengthening immune reactions offers greater promise to
mitigate future infections (Chandra, 1996; Davison et al., 2016;
Kostoff et al., 2020a,b; Tsatsakis et al., 2020). In Kostoff ’s view,
Frontiers in Research Metrics and Analytics | www.frontiersin.org 15 November 2020 | Volume 5 | Article 594060
Porter et al. Tracking and Mining COVID-19 Research
increased attention to factors that diminish immune system
capability is sorely needed. Study of their roles and ways to reduce
their effects on the populace should be directed at
➢ lifestyle factors (e.g., factors contributing to obesity, smoking,
alcohol and substance abuse)
➢ occupational/environmental factors (e.g., air pollution,
radiation exposures, chemical exposures, and even
deforestation—Dobson et al., 2020).
Opening LBD Opportunities
This article overviews our COVID-19 research profiling. As
noted, a keen aim in so doing is to inform LBD. We
actually intend to pursue discovery processes not limited to just
finding never-before investigated factors that could contribute
to mitigating COVID-19 or future viral threats. We want to
combine research knowledge accrued in COVID-19–related
research with additional knowledge resident in other literature.
Kostoff (Kostoff, 2011, 2019; Kostoff and Patel, 2014) labels this
“literature-related discovery and innovation,” but wewill use LBD
as shorthand.
Our COVID-19 topical analyses (see section Discussion) seek
to provide multiple means to get at essential and evolving topics.
They do not, in themselves, provide a menu of missing research
knowledge to guide LBD. We need a COVID-19 knowledge
model to structure efforts to resolve critical elements to mitigate
the pandemic and in turn point to needs that LBD might serve.
We see good potential in the use of the SEPs (Figure 4) as a
starting point, with the MeSH indexing helpful in organizing
knowledge resources. Compared to scientometric reviews on
COVID-19 (Colavizza et al., 2020; Kagan et al., 2020; Zhang
L. et al., 2020), our analyses, particularly with the engagement
of the SEPs, highlight the discovery of COVID-19’s historical
knowledge flows. This treats the full knowledge base, which then
become a distinctive feature of our work—that is, discovering
objective insights from the literature in a data-driven and
semiautomatic approach, with limited human intervention.
Preliminary results offer potential bases for future LBD
analyses. Consolidating topical entities from the current COVID-
19 abstracts and phrases is complemented by extraction
of MeSH terms in several categories. For instance, several
diseases (e.g., diabetes, hypertension, cardiovascular diseases,
anxiety) appear in the recent (2020) segment of our data,
whereas they were rarely mentioned in the pre-2020 related
coronavirus research. Contrast between COVID-19 research
(2020) and prior coronavirus research indicate emerging drugs
(e.g., hydroxycholoroquine, ribavirin, remdesivir, lopinavir).
Combinations provide another potential stepping stone (e.g.,
lopinavir and ritonavir). Also, certain genes show elevated
attention in the recent COVID-19 literature (e.g., S surface
glycoprotein [severe acute respiratory syndrome coronavirus
2]; ORF1ab polyprotein [Severe acute respiratory syndrome
coronavirus 2]; and N nucleocapsid phosphoprotein). Future
LBD probes could be started by scanning for topics linked to
such diseases, drugs, or genes associated with COVID-19 in other
(non–COVID-19) literatures.We plan to explore within PubMed
and beyond (e.g., WoS).
High on our future research agenda is to build on these
empirical topic summarizations to engage subject matter
experts in identifying critical gaps in understanding COVID-
19 and devising effective remedies. Table 4 arrays eight
categories pertaining to tactical and strategic approaches to
counter COVID-19 and future viral threats. Those categories
comprise a number of components (Supplementary Table 4),
some of which could warrant LBD ventures to introduce
remote research knowledge to enrich COVID-19 research
focuses. We will seek expert synthesis and extension of
our empirical topical information to identify problematic
virus attributes, critical biomechanisms, and biomarkers and
treatment approaches potentially suitable for “repurposing”
(Kostoff, 2019, 2020).
Application of artificial intelligence tools holds special
promise in organizing and exploring this research explosion.
Brainard (2020) notes more than 1,500 data science projects to
use the CORD-19 information resources to address COVID-
19 issues. We intend to direct VantagePoint machine learning
capabilities to help sort the COVID-19 topical content into the
categories just noted (c.f., MeSH categories, emergent topics,
tactical/strategic approaches). These can complement expert
knowledge by reducing the labor entailed—i.e., based on modest
trial datasets to auto-categorize more extensive COVID-19 and
out-of-domain record sets.
Once we have identified a small number of high-potential
topical elements, we will pursue complementary information
resources. We would start with PubMed (beyond COVID-19),
ClinicalTrials.gov, and Web of Science (to extend basic science
coverage). We are open to other sources as well.
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